[1]
L. Bazzichi, “Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study”, Reumatismo, vol. 66, no. 3, pp. 224-232, Nov. 2014.